Correlation of ABI1 and PTEN expression during prostate tumor progression.

被引：0
|
作者：
Kotula, Leszek
Hryniewicz-Jankowska, Anita
Li, Xiang
Augoff, Katarzyna
Papp, Csaba
Das, Disharee
Kung, Sonia H. Y.
Fazli, Ladan
Jasmaspishvili, Tamara
Berman, David Monty
Zhang, Fan
Porter, Baylee
Sikorski, Aleksander
Gleave, Martin
Kuznetsov, Vladimir
Bratslavsky, Gennady
机构：
[1] SUNY Upstate Med Univ, Syracuse, NY 13210 USA
[2] Univ British Columbia, Vancouver Prostate Ctr, Vancouver, BC, Canada
[3] Queens Univ, Kingston, ON, Canada
[4] Johns Hopkins Univ, Baltimore, MD USA
[5] Univ British Columbia, Vancouver, BC, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 06期
基金：
美国国家卫生研究院;
关键词：
D O I：
10.1200/JCO.2022.40.6_suppl.172
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
172
引用
收藏
页数：2
相关论文
共 50 条
  • [31] E-cadherin expression in clinically localized and hormone refractory prostate carcinoma by use of high-density tissue microarrays: Lack of correlation with tumor progression.
    Rubin, MA
    Figurski, J
    Mucci, NR
    Manley, S
    Day, ML
    LABORATORY INVESTIGATION, 2001, 81 (01) : 122A - 122A
  • [32] Involvement of hypoxia-inducible factor 1 in tumor progression.
    Semenza, GL
    Bedi, A
    Bhujwalla, Z
    Chiles, K
    De Marzo, A
    Feldser, D
    Hilton, D
    Laughner, E
    Ravi, R
    Simons, J
    Zagzag, D
    Zhong, H
    CLINICAL CANCER RESEARCH, 2000, 6 : 4483S - 4483S
  • [33] Abi1 loss drives prostate tumorigenesis through activation of EMT and non-canonical WNT signaling
    Disharee Nath
    Xiang Li
    Claudia Mondragon
    Dawn Post
    Ming Chen
    Julie R. White
    Anita Hryniewicz-Jankowska
    Tiffany Caza
    Vladimir A. Kuznetsov
    Heidi Hehnly
    Tamara Jamaspishvili
    David M. Berman
    Fan Zhang
    Sonia H. Y. Kung
    Ladan Fazli
    Martin E. Gleave
    Gennady Bratslavsky
    Pier Paolo Pandolfi
    Leszek Kotula
    Cell Communication and Signaling, 17
  • [34] Haploinsufficiency of the Pten tumor suppressor gene promotes prostate cancer progression
    Kwabi-Addo, B
    Giri, D
    Schmidt, K
    Podsypanina, K
    Parsons, R
    Greenberg, N
    Ittmann, M
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (20) : 11563 - 11568
  • [35] Discordance in hormone receptor status in breast cancer during tumor progression.
    Karlsson, E.
    Lindstrom, L. S.
    Wilking, U.
    Skoog, L.
    Johansson, U.
    Bergh, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [36] Tumor-associated neutrophils (TAN) develop protumorigenic properties during tumor progression.
    Mishalian, Inbal
    Bayuh, Rachel
    Zolotarov, Lida
    Levy, Liran
    Singhal, Sunil
    Albelda, Steven M.
    Fridlender, Zvi Gregorio
    CANCER RESEARCH, 2013, 73
  • [37] Abi1 loss drives prostate tumorigenesis through activation of EMT and non-canonical WNT signaling
    Nath, Disharee
    Li, Xiang
    Mondragon, Claudia
    Post, Dawn
    Chen, Ming
    White, Julie R.
    Hryniewicz-Jankowska, Anita
    Caza, Tiffany
    Kuznetsov, Vladimir A.
    Hehnly, Heidi
    Jamaspishvili, Tamara
    Berman, David M.
    Zhang, Fan
    Kung, Sonia H. Y.
    Fazli, Ladan
    Gleave, Martin E.
    Bratslavsky, Gennady
    Pandolfi, Pier Paolo
    Kotula, Leszek
    CELL COMMUNICATION AND SIGNALING, 2019, 17 (01)
  • [38] Role of CHD1 in cistrome reprogramming and prostate cancer progression.
    Augello, Michael A.
    Deonarine, Lesa
    Liu, Deli
    Dennis, Huang
    Doane, Ashley
    Rubin, Mark
    Elemento, Olivier
    Sboner, Andrea
    Dephoure, Noah
    Barbieri, Christopher
    CANCER RESEARCH, 2018, 78 (16) : 32 - 33
  • [39] Analysis of mRNA levels in prostate cancer; An investigation of endoglin as a prognostic marker of tumor progression.
    Clelland, CLT
    Bancroft, C
    Clelland, J
    AMERICAN JOURNAL OF HUMAN GENETICS, 2002, 71 (04) : 246 - 246
  • [40] Metabolism of saturated fatty acids accelerates Src-mediated prostate tumor progression.
    Kim, Sungjin
    Yang, Xiangkun
    Li, Qianjin
    Wu, Meng
    Beharry, Zanna
    Bartlett, Michael
    Bielawska, Alicja
    Cai, Houjian
    CANCER RESEARCH, 2018, 78 (16) : 64 - 64
12345